Rani Therapeutics Holdings, Inc.
RANI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,914 | -$6,692 | -$7,264 | -$15,722 |
| Dep. & Amort. | $223 | $240 | $251 | $266 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,343 | $0 | $0 | $3,991 |
| Change in WC | -$260 | $1,216 | $28 | -$1,132 |
| Other Non-Cash | $545 | -$560 | -$1,164 | $3,942 |
| Operating Cash Flow | -$5,063 | -$5,796 | -$8,149 | -$8,655 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$37 | -$51 | -$31 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$2,720 | -$17,748 |
| Inv. Sales/Matur. | $0 | $5,750 | $21,000 | $20,300 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $5,713 | $18,229 | $2,521 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,750 | -$3,750 | -$3,750 | -$3,750 |
| Stock Issued | $0 | $3,946 | $42 | $9,379 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,741 | -$8 | -$23 | -$10 |
| Financing Cash Flow | -$1,009 | $188 | -$3,731 | $5,619 |
| Forex Effect | $0 | $0 | -$0 | $0 |
| Net Chg. in Cash | -$6,072 | $105 | $6,349 | -$515 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,716 | $10,611 | $4,262 | $4,777 |
| End Cash | $4,644 | $10,716 | $10,611 | $4,262 |
| Free Cash Flow | -$5,063 | -$5,833 | -$8,200 | -$8,686 |